121 related articles for article (PubMed ID: 17299396)
41. Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats.
Wu H; Ren B; Zhu J; Dong G; Xu B; Wang C; Zheng X; Jing H
Eur J Cardiothorac Surg; 2006 Jun; 29(6):902-7. PubMed ID: 16675226
[TBL] [Abstract][Full Text] [Related]
42. Effects of recombinant human erythropoietin on neuropathic pain and cerebral expressions of cytokines and nuclear factor-kappa B.
Jia HB; Jin Y; Ji Q; Hu YF; Zhou ZQ; Xu JG; Yang JJ
Can J Anaesth; 2009 Aug; 56(8):597-603. PubMed ID: 19440808
[TBL] [Abstract][Full Text] [Related]
43. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer.
George ML; Dzik-Jurasz AS; Padhani AR; Brown G; Tait DM; Eccles SA; Swift RI
Br J Surg; 2001 Dec; 88(12):1628-36. PubMed ID: 11736977
[TBL] [Abstract][Full Text] [Related]
44. Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition.
Park SH; Choi MJ; Song IK; Choi SY; Nam JO; Kim CD; Lee BH; Park RW; Park KM; Kim YJ; Kim IS; Kwon TH; Kim YL
J Am Soc Nephrol; 2007 May; 18(5):1497-507. PubMed ID: 17389738
[TBL] [Abstract][Full Text] [Related]
45. [The research of the protection of recombinant human erythropoietin in human RPE cells by light-induced injuries].
Meng Y; Niu YJ; Qu H
Zhonghua Yan Ke Za Zhi; 2008 Jan; 44(1):50-5. PubMed ID: 18510244
[TBL] [Abstract][Full Text] [Related]
46. Relationship between microvessel quantification and inducibility of endogenous tumor necrosis factor in colorectal adenocarcinoma.
Yoshimura H; Chikamoto A; Honda T; Tashiro K; Nakamoto T; Takano M; Takagi K; Nagasue N; Soma G
Anticancer Res; 2000; 20(1C):629-33. PubMed ID: 10769707
[TBL] [Abstract][Full Text] [Related]
47. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
Gali-Muhtasib H; Sidani M; Geara F; Mona AD; Al-Hmaira J; Haddadin MJ; Zaatari G
Int J Oncol; 2004 May; 24(5):1121-31. PubMed ID: 15067333
[TBL] [Abstract][Full Text] [Related]
48. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury.
Li X; Gonias SL; Campana WM
Glia; 2005 Sep; 51(4):254-65. PubMed ID: 15812815
[TBL] [Abstract][Full Text] [Related]
49. Recombinant human erythropoietin prevents motor neuron apoptosis in a rat model of cervical sub-acute spinal cord compression.
Ning B; Zhang A; Song H; Gong W; Ding Y; Guo S; Zhao Y; Jiang J; Jia T
Neurosci Lett; 2011 Feb; 490(1):57-62. PubMed ID: 21167907
[TBL] [Abstract][Full Text] [Related]
50. Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.
Daldrup-Link HE; Okuhata Y; Wolfe A; Srivastav S; Øie S; Ferrara N; Cohen RL; Shames DM; Brasch RC
Microcirculation; 2004; 11(5):387-96. PubMed ID: 15280064
[TBL] [Abstract][Full Text] [Related]
51. Erythropoietin Plays a Protective Role in Submandibular Gland Hypofunction Induced by Irradiation.
Liu Q; Wang Y; Cui Z; Ma X; Shi H; Zhang W
J Oral Maxillofac Surg; 2021 Jun; 79(6):1373-1383. PubMed ID: 33412114
[TBL] [Abstract][Full Text] [Related]
52. Erythropoietin for patients undergoing radiotherapy: a pilot study.
Henke M; Guttenberger R; Barke A; Pajonk F; Pötter R; Frommhold H
Radiother Oncol; 1999 Feb; 50(2):185-90. PubMed ID: 10368042
[TBL] [Abstract][Full Text] [Related]
53. [Effects of Recombinant Human Erythropoietin on MPC-11 Myeloma Cells Cultured In Vitro].
Zeng Y; Zhou JL; Xu CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1460-1465. PubMed ID: 29070125
[TBL] [Abstract][Full Text] [Related]
54. The use of RNA-based 5'-aminolevulinate synthase 2 biomarkers in dried blood spots to detect recombinant human erythropoietin microdoses.
Loria F; Cox HD; Voss SC; Rocca A; Miller GD; Townsend N; Georgakopoulos C; Eichner D; Kuuranne T; Leuenberger N
Drug Test Anal; 2022 May; 14(5):826-832. PubMed ID: 34216436
[TBL] [Abstract][Full Text] [Related]
55. How bio-questionable are the different recombinant human erythropoietin copy products in Thailand?
Halim LA; Brinks V; Jiskoot W; Romeijn S; Praditpornsilpa K; Assawamakin A; Schellekens H
Pharm Res; 2014 May; 31(5):1210-8. PubMed ID: 24258097
[TBL] [Abstract][Full Text] [Related]
56. Erythropoietin re-wires cognition-associated transcriptional networks.
Singh M; Zhao Y; Gastaldi VD; Wojcik SM; Curto Y; Kawaguchi R; Merino RM; Garcia-Agudo LF; Taschenberger H; Brose N; Geschwind D; Nave KA; Ehrenreich H
Nat Commun; 2023 Aug; 14(1):4777. PubMed ID: 37604818
[TBL] [Abstract][Full Text] [Related]
57. Recombinant human erythropoietin accelerated the proliferation of non-small cell lung cancer cell lines and reduced the expression of VEGF, HIF-1α, and PD-L1 under a simulated hypoxic environment in vitro.
Zhang Y; Feng Y; Sun X
Chronic Dis Transl Med; 2022 Jun; 8(2):124-133. PubMed ID: 35774428
[TBL] [Abstract][Full Text] [Related]
58. Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.
Delrue LJ; Casneuf V; Van Damme N; Blanckaert P; Peeters M; Ceelen WP; Duyck PC
MAGMA; 2011 Aug; 24(4):225-32. PubMed ID: 21567161
[TBL] [Abstract][Full Text] [Related]
59. Novel avenues of drug discovery and biomarkers for diabetes mellitus.
Maiese K; Chong ZZ; Shang YC; Hou J
J Clin Pharmacol; 2011 Feb; 51(2):128-52. PubMed ID: 20220043
[TBL] [Abstract][Full Text] [Related]
60. Oxidative stress: Biomarkers and novel therapeutic pathways.
Maiese K; Chong ZZ; Hou J; Shang YC
Exp Gerontol; 2010 Mar; 45(3):217-34. PubMed ID: 20064603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
